Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
NCT Number: NCT01794221
The objective of this study is to evaluate whether 2-octyl cyanoacrylate skin adhesive decreased the incidence of recurrent adhesions after circumcision. The investigators hypothesize that the incidence of recurrent adhesions will be decreased with use of 2-octyl cyanoacrylate skin adhesive.
Looking for future studies?
Notify Me1 day–7 year
Male
Interventional
Not applicable
Kansas City, Missouri, 64108, United States
The objective of this study is to evaluate whether 2-octyl cyanoacrylate skin adhesive decreased the incidence of recurrent adhesions after circumcision. The investigators hypothesize that the incidence of recurrent adhesions will be decreased with use of 2-octyl cyanoacrylate skin adhesive.
Secondary Objective(s) To assess parent satisfaction and comfort level after circumcision with use of 2-octyl cyanoacrylate skin adhesive and compare to those undergoing circumcision without the use of 2-octyl cyanoacrylate skin adhesive.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In addition to stitches, 2-octyl cyanoacrylate skin adhesive will be applied to the circumcision wound.
Other names: skin adhesive
standard of care
Time frame: 3-6 weeks
Evaluation for adhesions
Time frame: 3-6 weeks
Parent survey at follow-up visit.
Children's Mercy Hospital Kansas City
Other
Acronym: Circglue
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06487494
Genital Diseases, Genital Diseases, Male
Winnipeg, Manitoba, Canada
View Trial DetailsNCT04646967
Balanitis, Genital Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT04755803
Chordee, Concealed Penis
Seoul, South Korea
View Trial DetailsNCT04698434
Genital Diseases, Genital Diseases, Male
Yangzhou, Jiangsu, China
View Trial Details